|
| 34993496 | Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. | HGG Adv | 2022 |
| 35970474 | Radiologist Preferences for Artificial Intelligence-Based Decision Support During Screening Mammography Interpretation. | J Am Coll Radiol | 2022 |
| 33713608 | Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. | Am J Hum Genet | 2021 |
| 32226005 | DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs. | PLoS Genet | 2020 |
| 32071439 | Copy number alterations are associated with metastatic-lethal progression in prostate cancer. | Prostate Cancer Prostatic Dis | 2020 |
| 32130059 | 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort. | J Clin Oncol | 2020 |
| 26902887 | DNA methylation profiles in African American prostate cancer patients in relation to disease progression. | Genomics | 2019 |
| 31376183 | A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies. | Prostate | 2019 |
| 30464020 | Vigorous Physical Activity Is Associated with Lower Risk of Metastatic-Lethal Progression in Prostate Cancer and Hypomethylation in the <i>CRACR2A</i> Gene. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 29298992 | Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases. | Prostate Cancer Prostatic Dis | 2018 |
| 29956356 | A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. | Prostate | 2018 |
| 27358489 | Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. | Clin Cancer Res | 2017 |
| 28496006 | Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. | Oncotarget | 2017 |
| 28145099 | Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer. | Mol Oncol | 2017 |
| 27902461 | Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes. | Oncotarget | 2017 |
| 26818005 | Trichomonas vaginalis infection and risk of advanced prostate cancer. | Prostate | 2016 |
| 27587788 | A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. | Cancer Epidemiol Biomarkers Prev | 2016 |
| 27142338 | Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes. | Cancer | 2016 |
| 27401406 | Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer. | Diagn Pathol | 2016 |
| 26804755 | Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy. | J Urol | 2016 |
| 26823525 | Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. | J Natl Cancer Inst | 2016 |
| 25044450 | Generalizability of established prostate cancer risk variants in men of African ancestry. | Int J Cancer | 2015 |
| 26162851 | Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. | Hum Mol Genet | 2015 |
| 26125186 | Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults. | PLoS One | 2015 |
| 25852077 | Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status. | Am J Epidemiol | 2015 |
| 25990700 | Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort. | Prostate | 2015 |
| 25939597 | Two susceptibility loci identified for prostate cancer aggressiveness. | Nat Commun | 2015 |
| 24718283 | Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. | Cancer Epidemiol Biomarkers Prev | 2014 |
| 25217961 | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. | Nat Genet | 2014 |
| 22549291 | Association of variants in estrogen-related pathway genes with prostate cancer risk. | Prostate | 2013 |
| 23833122 | Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility. | Cancer Epidemiol Biomarkers Prev | 2013 |
| 23972671 | Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis. | Cancer Epidemiol | 2013 |
| 23633265 | Statin use in relation to prostate cancer outcomes in a population-based patient cohort study. | Prostate | 2013 |
| 23535732 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. | Nat Genet | 2013 |
| 23583978 | A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. | Nat Genet | 2013 |
| 23129385 | HOXB13 mutations in a population-based, case-control study of prostate cancer. | Prostate | 2013 |
| 23065704 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. | Hum Mol Genet | 2013 |
| 22887727 | Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression. | Hum Mutat | 2013 |
| 22542949 | Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. | Cancer Epidemiol | 2012 |
| 22832964 | Genome-wide meta-analyses of smoking behaviors in African Americans. | Transl Psychiatry | 2012 |
| 21430300 | Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. | Cancer Epidemiol Biomarkers Prev | 2011 |
| 21846818 | Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. | Cancer Epidemiol Biomarkers Prev | 2011 |
| 21637779 | Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. | PLoS Genet | 2011 |
| 21602798 | Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. | Nat Genet | 2011 |
| 21743467 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. | Nat Genet | 2011 |
| 21705483 | Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. | Carcinogenesis | 2011 |
| 21467234 | Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. | Cancer Epidemiol Biomarkers Prev | 2011 |
| 20503394 | CYP17 polymorphisms and prostate cancer outcomes. | Prostate | 2010 |
| 19836772 | Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. | J Urol | 2009 |
| 18571837 | Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. | Cancer Lett | 2008 |